Thrivent Financial for Lutherans
AGN.PRA

Thrivent Financial for Lutherans’s Allergan plc AGN.PRA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,950
Closed -$3.65M – 2377
2017
Q3 		$3.65M Buy
4,950
+500
+11% +$415K 0.01% 697
2017
Q2 		$3.86M Hold
4,450
– – 0.02% 653
2017
Q1 		$3.77M Buy
4,450
+300
+7% +$249K 0.02% 668
2016
Q4 		$3.17M Buy
4,150
+650
+19% +$491K 0.01% 721
2016
Q3 		$2.87M Hold
3,500
– – 0.01% 759
2016
Q2 		$2.92M Buy
3,500
+3,000
+600% +$2.51M 0.01% 755
2016
Q1 		$460K Sell
500
-1,000
-67% -$956K ﹤0.01% 1404
2015
Q4 		$1.55M Hold
1,500
– – 0.01% 926
2015
Q3 		$1.42M Hold
1,500
– – 0.01% 878
2015
Q2 		$1.57M Buy
+1,500
New +$1.57M 0.01% 723

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Thrivent Financial for Lutherans's AGN.PRA Position: Q4 2017 in Review

Thrivent Financial for Lutherans sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 4,950 shares — an estimated $3.65M sold.

Thrivent Financial for Lutherans first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $3.86M in Q2 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Thrivent Financial for Lutherans reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 4,950 Allergan plc shares in Q4 2017, an estimated $3.65M.
  • Thrivent Financial for Lutherans first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Thrivent Financial for Lutherans's Allergan plc position peaked at $3.86M in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2017, filed 14 Feb 2018.